WHO is marking International Migrants Day on 18 December 2018 with the launch of a technical guidance series on the health of refugees and migrants. Produced in collaboration with the European Commission, each publication addresses a specific aspect of the health of refugees and migrants by providing tools, case studies and evidence to inform practices and policies to improve their health.
EMA has published a plan outlining how it would respond to an emerging cross-border threat to health, such as an influenza pandemic.
The health threats plan is based on the Agency’s pandemic influenza plan published in 2006 and reflects experience gained during the 2009 (H1N1) influenza pandemic as well as the Ebola outbreak in Western Africa in 2014-2016. The plan would also be triggered in the event of acute hazards including threats of chemical, environmental and unknown origin.
World Health Organization Commended stronger tobacco control measures being adopted by Thailand which has become the first in Asia and the first low and middle-income country to adopt plain packaging for tobacco products.
Researchers at MIT, Draper, and Brigham and Women’s Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user’s smartphone.
Protecting patient safety is at the core of the FDA’s mission. All FDA-approved drugs have benefits and risks which must be weighed and balanced by health care providers and patients when making decisions about medical therapy. Our goal is to ensure that the benefits and risks are clearly articulated in drug labeling. That patients and providers have accurate information. And that the benefits outweigh the risks for the intended patient population.
In general, women who have had children have a lower risk of breast cancer compared to women who have never given birth. However, new research has found that moms don’t experience this breast cancer protection until many years later and may face elevated risk for more than 20 years after their last pregnancy.
The Global Health Innovative Technology (GHIT) Fund announced a total of 520 million yen (US$ 4.6 million) to support four partnerships to develop new lifesaving drugs and vaccines for malaria, tuberculosis, dengue and leishmaniasis. This includes three new projects and one that will receive continued funding.
Ensuring the safety of our nation’s drug supply is a cornerstone of our consumer protection mission. Overseeing the quality and safety of pharmaceutical manufacturing is key to these efforts. With the emergence of new markets, supply chains are more complex. Drug production and testing operations have also become more computerized. These changes represent new opportunities and challenges.
Researchers at Stanford University, Palo Alto, California, have created a noninvasive technology that detects when nerve cells fire based on changes in shape. The method could be used to observe nerve activity in light-accessible parts of the body, such as the eye, which would allow physicians to quantitatively monitor visual function at the cellular level. The study was published in the journal Light: Science and Applications. The work was funded by the National Eye Institute, part of the National Institutes of Health.
WHO is proud to partner with Luxembourg, a strong supporter of global health, that contributes more than 15% of its official development assistance to the health sector. Since 2009, Luxembourg has provided 1% of its gross national income to development assistance, one of the few countries that exceeds the United Nations target of 0.7%.